We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Feb 2023 - 09 Feb 2023

World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear

By LabMedica International staff writers
Posted on 19 Jan 2023
Print article
A global study has paved the way for the development of the world’s first test to detect diabetics at risk of kidney disease (Photo courtesy of Monash University)
A global study has paved the way for the development of the world’s first test to detect diabetics at risk of kidney disease (Photo courtesy of Monash University)

Millions of people with diabetes live with chronic kidney disease and have a poorer chance of survival. The current standard assays used in clinics depend on assessing kidney function and the extent of kidney damage caused by diabetes. However, there are usually no symptoms during the early stages of the disease. There have been huge advances in genetic testing, although risk genes for diabetic kidney disease (DKD) have yet to be identified. Now, an international team of researchers have identified the genetic markers for people with diabetes who are at a risk of developing kidney disease. This paves the way for the development of a test that could identify adults with Type 1 diabetes who are at a risk of kidney disease before they show any symptoms, enabling the introduction of early-stage interventions by doctors.

In the world’s first international study led by Monash University (Melbourne, Australia), the researchers tested the genes in 1017 Scandinavian and Asian diabetes cohorts and examined a process called methylation, in which a small molecule called a methyl group gets added to DNA. The findings from the largest-ever international study on Type 1 diabetes revealed that “important clues that reduced DNA methylation is closely associated with the increased risk of diabetes relate kidney disease,” said Professor Sam El-Osta, from Central Clinical School, Human Epigenetics team at the Department of Diabetes at Monash University. “These discoveries will influence how we screen patients with diabetes and improve risk stratification, disease prediction and diagnosis.”

“The team at Monash University's Central Clinical School using innovative sequencing techniques developed gene methylation risk scores that are tightly associated with early detection and the development of diabetic kidney disease,” added Professor El-Osta. “Scientists searching for blood-based biomarkers in diabetes cohorts originating from Finland, Denmark, Hong Kong and Thailand, found surprising commonality in gene methylation risk scores. They note that the innovative sequencing technologies developed using the internal collaboration revealed missing methylation data that was ultimately used to develop a predictive test for diabetic kidney disease.”

“As far as technological advancements in methods are concerned, epigenetic testing is going to be the new standard for early detection and DKD care,” explained Professor El-Osta. “Renal biopsies are difficult to procure and the novel blood-based test means the test can be readily available and used in remote areas with the added advantage of being more stable than methods measuring other biological indices.”

Gold Supplier
STI Real-Time PCR Test
Neisseria Gonorrhoeae/Chlamydia Trachomatis/U.urealyticum Real-Time PCR Kit
New
Rapid H. Pylori Antibody Test
Reveal HP
New
Portable Molecular Test Device
CLEO ONE
New
Rapid Fecal Occult Blood (FOB) Test
Advanced Quality Rapid FOB Test

Print article
MEDLAB - INFORMA

Channels

Immunology

view channel
Image: Histopathology of Langerhans cell histiocytosis: The variation in nuclear contours of these cells is evident in this lesion. Classic `kidney bean` nuclei of Langerhans cells with a central groove are present (Photo courtesy of John Lazarchick, MD)

Cooperativity Between Myeloid Lineages Promotes Langerhans Cell Histiocytosis Pathology

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia seen in children and adults who present with lesions composed of pathologic variants of myeloid cells that share certain phenotypic... Read more

Microbiology

view channel
Image: Medical illustration of Carbapenem-resistant Enterobacteriacea (Photo courtesy of CDC, Stephanie Rossow)

Breakthrough Test Enables Targeted Antibiotic Therapy for Various Enterobacter Species

Bacteria of the Enterobacter genus are considered to be the most dangerous bacteria linked to hospital infections across the world. Some of their representatives demonstrate high resistance to commonly-used... Read more

Technology

view channel
Image: Flexible copper sensor made cheaply from ordinary materials (Photo courtesy of University of São Paulo)

Low-Cost Portable Sensor Detects Heavy Metals in Sweat

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. However, they become toxic if they accumulate in the human body... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.